EPISODE · Jan 20, 2023 · 8 MIN
In conversation with... Ellisiv Mathiesen
from Listen to The Lancet Neurology · host The Lancet
Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology.
NOW PLAYING
In conversation with... Ellisiv Mathiesen
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.